Nanopore Diagnostics

Nanopore Diagnostics, LLC specializes in developing rapid and portable diagnostic products for bacterial infections. Founded in 2011 and based in St. Louis, Missouri, the company has created the iNDxer, a nanopore sensor designed to count dilute nucleic acid biomarkers in minimally processed samples. This technology enables the identification of RNA markers specific to pathogenic bacteria, allowing physicians to determine the presence of harmful microbes efficiently. By providing accurate diagnostics at the point of care, Nanopore Diagnostics aims to inform antibiotic treatment decisions, thereby reducing healthcare costs and combating antibiotic resistance.